Join
Live feed
·
INSIDERFilingvia Quantisnow
AN2 Therapeutics Inc. logo

Chief Medical Officer Trenor Cameron C. Iii was granted 116,667 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ANTX· AN2 Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANTX (AN2 Therapeutics Inc.) and more on Quantisnow.